Eyevance Pharmaceuticals appoints chief commercial officer

Eyevance Pharmaceuticals added Julie Speed to its executive team as the chief commercial officer, onboarding a leader with more than 21 years of experience.

Advertisement

What you should know:

1. Ms. Speed will develop a commercial strategy for the company’s Eyevance product portfolio.

2. She comes to Eyevance from Johnson & Johnson Vision where she most recently served as senior director of U.S. marketing.

3. Ms. Speed has a storied career, including tenures at TearLab Corp., and Alcon.

She commented on Eyevance’s portfolio, saying, “Eyevance’s robust product pipeline of commercial and development-stage assets have the opportunity to address many unmet ophthalmic market needs, which will position the organization for sustained success in 2020 and beyond.”

More articles on surgery centers:
ASC supply chain tip of the day: Prepare for shortages
3 recent updates on Medline
6 ASC supply chain tips
 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.